Get the Stockscreener App
0.4632
0.00%
+0.0032
Redhill Biopharma Ltd. ADR Stock (RDHL) Forecast
The Redhill Biopharma Ltd. ADR (RDHL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $25.54, representing a +5,413% increase from the current price of $0.4632. The highest analyst price target is $26.55, and the lowest is $24.52.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RDHL Price Target
Average 39.47
(+8,421% Upside)
Is Redhill Biopharma Ltd. ADR (RDHL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.61 | Neutral |
| STOCH(9,6) | 65.76 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.00384 | Buy |
| ADX(14) | 20.81 | Neutral |
| William %R | -12.20 | Sell |
| CCI(14) | 106.44 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4574
Buy
|
0.4564
Buy
|
| MA20 |
0.4463
Buy
|
0.4551
Buy
|
| MA50 |
0.4778
Sell
|
0.4993
Sell
|
| MA100 |
0.6634
Sell
|
0.6361
Sell
|
| MA200 |
0.7317
Sell
|
1.3002
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, RDHL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on RDHL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 51.61 indicates that RDHL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.76 indicates that RDHL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RDHL is oversold. This suggests that RDHL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.81 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 106.44 indicates that RDHL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RDHL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Redhill Biopharma Ltd. ADR financial reports and earnings history, Redhill Biopharma Ltd. ADR (RDHL) stock could reach $314.53 by 2030, $203.19 by 2040 and $605.09 by 2050. See the projected annual prices until 2050 of the Redhill Biopharma Ltd. ADR stock below:
- Redhill Biopharma Ltd. ADR (RDHL) is expected to reach an average price of $59.77 in 2035, with a high prediction of $68.03 and a low estimate of $59.77. This indicates an $12,803% rise from the last recorded price of $0.4632.
- Redhill Biopharma Ltd. ADR (RDHL) stock is projected to chart a bullish course in 2040, with an average price target of $195.49, representing an $42,103% surge from its current level. The forecast ranges from a conservative $195.74 to a sky-high $203.19.
- Our analysts predict Redhill Biopharma Ltd. ADR (RDHL) to jump 82,263% by 2045, soaring from $383.95 to an average price of $381.50, potentially reaching $383.73. While $383.95 is the low estimate, the potential upside is significant.
- Redhill Biopharma Ltd. ADR (RDHL) stock is expected to climb by 2050, reaching an average of $575.80, a $124.21K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $605.09 and $609.25, respectively, highlighting the market's uncertainty.
Redhill Biopharma Ltd. ADR Stock (RDHL) Year by Year Forecast
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2024
Our forecast for RDHL stock price in 2024 now indicates an average price target of $30.90 with a high forecast of $61.50 and a low forecast of $0.30. The average prediction reflects an increase of +6,571% from the last recorded price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $43.75 | $24.52 | $26.55 | +9,345% |
| July, 2024 | $33.67 | $3.419 | $41.02 | +7,168% |
| August, 2024 | $3.8402 | $23.04 | $17.81 | +729.07% |
| September, 2024 | $13.99 | $6.787 | $39.87 | +2,920% |
| October, 2024 | $30.73 | $8.5562 | $15.04 | +6,534% |
| November, 2024 | $7.7019 | $8.3587 | $61.50 | +1,563% |
| December, 2024 | $13.07 | $27.97 | $23.59 | +2,723% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2025
Redhill Biopharma Ltd. ADR Stock (RDHL) is expected to reach an average price of $113.84 in 2025, with a high prediction of $226.34 and a low estimate of $1.3453. This indicates an +24,477% rise from the last recorded price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $33.39 | $34.71 | $24.25 | +7,109% |
| February, 2025 | $55.16 | $32.88 | $25.16 | +11,809% |
| March, 2025 | $97.34 | $64.11 | $61.45 | +20,914% |
| April, 2025 | $76.05 | $88.45 | $74.02 | +16,319% |
| May, 2025 | $33.37 | $13.37 | $75.52 | +7,105% |
| June, 2025 | $20.00 | $1.3453 | $112.83 | +4,218% |
| July, 2025 | $26.09 | $13.32 | $63.43 | +5,532% |
| August, 2025 | $30.71 | $15.14 | $72.20 | +6,531% |
| September, 2025 | $114.94 | $4.1701 | $128.54 | +24,714% |
| October, 2025 | $67.82 | $56.62 | $172.80 | +14,543% |
| November, 2025 | $183.25 | $71.48 | $226.34 | +39,462% |
| December, 2025 | $114.14 | $101.54 | $212.28 | +24,541% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2026
The predicted value for Redhill Biopharma Ltd. ADR (RDHL) in 2026 is set at an average of $138.45. Estimates vary from a peak of $276.61 to a trough of $0.2891, indicating an +29,789% surge from the present price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $137.96 | $91.45 | $162.51 | +29,685% |
| February, 2026 | $130.19 | $109.93 | $152.99 | +28,007% |
| March, 2026 | $89.62 | $66.42 | $188.85 | +19,247% |
| April, 2026 | $234.10 | $93.47 | $246.10 | +50,440% |
| May, 2026 | $102.73 | $77.01 | $259.56 | +22,078% |
| June, 2026 | $98.56 | $70.16 | $115.77 | +21,177% |
| July, 2026 | $60.24 | $47.84 | $102.41 | +12,905% |
| August, 2026 | $108.47 | $55.70 | $121.67 | +23,317% |
| September, 2026 | $81.75 | $68.95 | $111.12 | +17,549% |
| October, 2026 | $110.38 | $58.01 | $113.46 | +23,729% |
| November, 2026 | $233.41 | $88.09 | $276.61 | +50,290% |
| December, 2026 | $17.89 | $0.2891 | $255.13 | +3,762% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Redhill Biopharma Ltd. ADR (RDHL) is $53.73, with a high forecast of $98.92 and a low forecast of $8.5459. This indicates an +11,500% increase from the last price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $71.72 | $8.5459 | $98.92 | +15,383% |
| February, 2027 | $43.66 | $34.09 | $83.97 | +9,325% |
| March, 2027 | $45.57 | $46.74 | $36.17 | +9,739% |
| April, 2027 | $48.55 | $52.12 | $42.95 | +10,380% |
| May, 2027 | $41.92 | $46.32 | $44.43 | +8,950% |
| June, 2027 | $68.63 | $50.06 | $49.43 | +14,717% |
| July, 2027 | $32.81 | $33.21 | $57.98 | +6,983% |
| August, 2027 | $48.18 | $32.95 | $42.18 | +10,301% |
| September, 2027 | $81.30 | $62.72 | $81.30 | +17,451% |
| October, 2027 | $94.43 | $80.24 | $84.67 | +20,286% |
| November, 2027 | $76.44 | $82.63 | $81.90 | +16,403% |
| December, 2027 | $67.96 | $73.16 | $76.87 | +14,571% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2028
In 2028, Redhill Biopharma Ltd. ADR (RDHL) is projected to reach an average price of $67.11, with a high projection of $79.97 and a low estimate of $54.24. This indicates an +14,387% rise from the last price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $71.47 | $70.38 | $70.79 | +15,329% |
| February, 2028 | $81.80 | $71.87 | $76.50 | +17,560% |
| March, 2028 | $68.78 | $70.58 | $76.56 | +14,750% |
| April, 2028 | $76.96 | $70.74 | $72.79 | +16,515% |
| May, 2028 | $80.77 | $78.13 | $79.97 | +17,337% |
| June, 2028 | $75.98 | $76.28 | $79.70 | +16,303% |
| July, 2028 | $70.25 | $70.65 | $71.58 | +15,067% |
| August, 2028 | $65.45 | $65.73 | $68.40 | +14,031% |
| September, 2028 | $65.88 | $65.92 | $65.35 | +14,123% |
| October, 2028 | $62.77 | $62.87 | $64.60 | +13,450% |
| November, 2028 | $57.50 | $57.54 | $61.31 | +12,314% |
| December, 2028 | $54.20 | $54.24 | $56.39 | +11,602% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2029
The 2029 price forecast for Redhill Biopharma Ltd. ADR Stock (RDHL) is $145.68 on average, with a high prediction of $290.30 and a low estimate of $1.0701. This represents an +31,352% increase from the previous price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $48.84 | $48.88 | $53.06 | +10,444% |
| February, 2029 | $44.98 | $45.01 | $47.73 | +9,611% |
| March, 2029 | $40.82 | $40.88 | $43.92 | +8,712% |
| April, 2029 | $37.12 | $37.18 | $39.59 | +7,913% |
| May, 2029 | $31.85 | $31.85 | $35.60 | +6,776% |
| June, 2029 | $26.27 | $26.35 | $30.72 | +5,571% |
| July, 2029 | $22.24 | $22.33 | $24.87 | +4,701% |
| August, 2029 | $17.84 | $17.86 | $21.10 | +3,751% |
| September, 2029 | $13.65 | $13.68 | $16.76 | +2,847% |
| October, 2029 | $8.4229 | $8.4341 | $12.48 | +1,718% |
| November, 2029 | $4.2255 | $4.3775 | $7.298 | +812.25% |
| December, 2029 | $310.70 | $1.0701 | $290.30 | +66,976% |
Redhill Biopharma Ltd. ADR Stock (RDHL) Price Forecast for 2030
Redhill Biopharma Ltd. ADR Stock (RDHL) is expected to reach an average price of $307.69 in 2030, with a high forecast of $334.45 and a low forecast of $280.94. This signifies an +66,328% surge from the last price of $0.4632.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $323.73 | $322.47 | $314.53 | +69,790% |
| February, 2030 | $307.28 | $337.62 | $330.30 | +66,238% |
| March, 2030 | $322.82 | $297.16 | $316.93 | +69,594% |
| April, 2030 | $283.17 | $308.37 | $312.19 | +61,033% |
| May, 2030 | $294.20 | $280.94 | $283.20 | +63,414% |
| June, 2030 | $315.34 | $301.29 | $291.57 | +67,980% |
| July, 2030 | $320.38 | $289.92 | $301.98 | +69,066% |
| August, 2030 | $315.12 | $304.24 | $296.33 | +67,932% |
| September, 2030 | $296.27 | $305.07 | $296.29 | +63,861% |
| October, 2030 | $329.30 | $301.75 | $326.10 | +70,992% |
| November, 2030 | $346.85 | $359.36 | $334.45 | +74,780% |
| December, 2030 | $321.99 | $335.99 | $329.82 | +69,414% |
0.10%
0.18%
Cap:
|
Volume (24h):